
Sign up to save your podcasts
Or


May was Bladder Cancer Awareness Month, so we wanted to share a conversation with Dr. Yair Lotan on the state of bladder cancer awareness and research, his work with the Bladder Cancer Advocacy Network, and some of the advancements in bladder cancer research that most excite him. Dr. Lotan is a urology professor and chief of urologic oncology at University of Texas Southwestern Medical Center in Dallas, Texas. He's known nationally for his research on urine markers and molecular markers, which will help determine patients at higher risk for recurrent cancer. Bladder cancer is the sixth most common cancer diagnosed annually in the U.S., according to the National Library of Medicine. This is the second part of a two-part conversation we conducted with Dr. Lotan. In the first, we discussed a micro-cost analysis published in Urology that broke down per-procedural costs for cystoscopy and explored how single-use cystoscopes might provide a cost-effective option for providers.
Dr. Lotan is an Ambu consultant.
Show notes:
In this conversation, we discuss why this kind of analysis is significant and what the findings reveal about the safe and effective cleaning of endoscopes.
Dr. Muscarella is an Ambu consultant.
Show notes:
Contamination of Flexible Endoscopes and Associated Infections: A Comprehensive Review and Analysis of FDA Adverse Event Reports
Bio: Dr. Larry Muscarella
Medtech Insight - Study: FDA Data Shows Endoscope-Related Adverse Events Continue to Rise
FDA Pushes Switch to 'Innovative' Duodenoscope Designs to Enhance Patient Safety
Urological Endoscope Manufacturer Issues 'Urgent' Recall
Urologists with Henry Ford Health System were forced to quickly pivot and take all their patients coming in for clinic appointments and procedures and push them to a downtown Detroit campus. Single-use cystoscopy technology enabled them to do just that.
Dr. Craig Rogers explains how in the latest episode of Endoscopy Insights. What happened is a testament to the power of new technology at a time when healthcare systems find themselves challenged on several fronts — clinical, financial, supply chain and logistics, even staffing.
Show notes:
Case Study: How This Urologist Kept Caring for Patients After His Clinic Flooded
Bio: Dr. Craig Rogers
Henry Ford Health System
U.S. News: States With the Biggest Hospital Staffing Shortages
Subscribe to Endoscopy Insights
One of the authors of that study, Dr. Yair Lotan, is our guest on the newest episode of Endoscopy Insights and he walks us through his findings. Factors such as capital equipment costs, labor, and supply costs, as well as the number of procedures performed each year, impact the price of cystoscopy.
Dr. Lotan is a urology professor and chief of urologic oncology at University of Texas Southwestern Medical Center in Dallas, Texas.
Dr. Marybeth Spanarkel loved the "immediate gratification" in performing a colonoscopy or upper GI endoscopy and getting an immediate answer to a medical question.
Unfortunately, she had to step away from the field after 28 years in private practice in Durham, North Carolina, after a career-ending neck injury that caused sudden paralysis in her right arm. That musculoskeletal injury brought her career to an end, but it was the catalyst sending her down a new path — keeping other GI endoscopists from suffering a similar fate by educating them on the unique ergonomics challenges they face.
In this episode of Endoscopy Insights, we delve into ergonomics issues and training and also discuss her work on the development of an abdominal compression device used to prevent ergonomics injuries. Show notes:
Hospitals that perform bronchoscopies can reduce readmission rates by over half, and potentially lower costs, by adopting single-use flexible bronchoscopes.
That's according to a new abstract that was submitted and presented at the recently completed CHEST 2021 annual meeting. The study examined the health outcomes of more than 14,000 patients who underwent a bronchoscopy procedure and found that sterile, single-use bronchoscopes reduced the re-admissions rate 53 percent, from 7.7 percent to 3.6 percent, compared with reusable bronchoscopes.
Dr. Hudson Garrett joined Endoscopy Insights to discuss the findings. In our conversation, he talks about why readmission rates are such an important performance metric for hospitals, the key clinical findings he identified in looking at this data, and the larger quality-of-care and patient safety conversations taking place in healthcare.
Garrett is an Ambu consultant.
A recent study conducted at Duke University Hospital and published in the Journal of Endourology found that a new single-use cystoscope demonstrated superior flexion and comparable optics to the reusable scopes already being used in a hospital urology department.
Dr. Michael Lipkin, a urologist in Durham, North Carolina, and one of the study's authors, joined Endoscopy Insights to discuss the findings. In our conversation, he talks about the key technological capabilities of the cystoscopes that he and his fellow researchers set out to assess, and other factors that impact the calculus of single-use vs. reusable.
Lipkin also touches on a physician feedback survey that was done as part of the research and what his fellow urologists had to say, and other issues such as cost, infection prevention, and environmental factors.
The U.S. Food and Drug Administration revealed in a letter to healthcare providers that it's investigating numerous medical device reports describing patient infections and other possible contamination issues potentially associated with reprocessed urological endoscopes. Dr. Larry Muscarella delves into more detail on reprocessing best practices and some of the challenges therein. He also shares his key takeaways from the FDA letter — for clinicians, regulators and healthcare consumers alike.
The U.S. Food and Drug Administration is investigating "numerous" medical device reports (MDRs) describing patient infections and other possible contamination issues possibly associated with reprocessed urological endoscopes. Dr. Larry Muscarella, an independent safety expert who advises hospitals, manufacturers and the public about medical device safety and infection prevention, talks about the letter to healthcare providers from the FDA. He also breaks down what it means, what surprised him about this latest course of action surrounding endoscopes and reprocessing, and what to watch for next.
From the publisher's feed